Allegra Medical Technologies (ASX: AMT) Share Price and News

Price

$0.029

Movement

( )

as at 15 Nov - Closed (20 mins delayed)

52 Week Range

$0.022 - $0.058

 
1 Year Return

-44.23%

Allegra Medical Technologies Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

$0.029

Day Change

( )

52 Week Range

$0.022 - $0.058

Yesterday's Close

$0.029

Today's Open

Days Range

-

Volume

0

Avg. Volume (1 month)

0

Turnover

$0

as at 15 Nov - Closed

Allegra Medical Technologies (ASX: AMT)
Latest News

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Share Market News

Allegra (ASX:AMT) share price lifts 6% after reporting loss

The Allegra (ASX: AMT) share price jumped up 6.45% today after the company released its half-yearly results. Here are the…

Read more »

Share Market News

Why the Allegra (ASX:AMT) share price is rocketing 20% higher today

The Allegra Orthopaedics Ltd (ASX: AMT) share price is surging today after the company announced an update on its flagship…

Read more »

AMT ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
14th Nov 2024 2024-11-14T10:00:09 Removal from Official ListYesNo10:00am190k
31st Oct 2024 2024-10-31T09:04:45 AGM Extension AnnouncementYesNo9:04am1103k
18th Oct 2024 2024-10-18T16:15:54 Long Term Suspended EntitiesYesNo4:15pm8200k
15th Oct 2024 2024-10-15T14:15:32 Notice of compulsory acquisitionYesNo2:15pm5365k
10th Oct 2024 2024-10-10T09:09:40 Shareholders UpdateYesNo9:09am1124k
9th Oct 2024 2024-10-09T12:45:39 Supplementary Bidder's StatementYesNo12:45pm3119k
7th Oct 2024 2024-10-07T08:17:35 Change in substantial holdingYesNo8:17am4115k
4th Oct 2024 2024-10-04T15:38:12 Initial Director's Interest NoticeYesNo3:38pm2207k
4th Oct 2024 2024-10-04T15:36:42 Final Director's Interest Notice - PKYesNo3:36pm2194k
3rd Oct 2024 2024-10-03T11:38:24 Changes to Allegra Directors and Non-Executive ChairmanYesNo11:38am1103k

About Allegra Medical Technologies

Allegra Orthopaedics Ltd. engages in the designing, prototyping and manufacturing of medical devices and surgical implants. It offers orthopaedic, spinal products, medical devices and consulting services. The company was founded by Gregory James Roger in September 1994 and is headquartered in Lane Cove West, Australia.

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
29 Aug 2024 Peter Kazacos Sell 946,470 $3,785
Off-market takeover.
29 Aug 2024 Peter Kazacos Sell 110,850 $443
Off-market takeover.
29 Aug 2024 Sean Mulhearn Sell 444,444 $1,777
Off-market takeover.
29 Aug 2024 Sean Mulhearn Sell 444,444 $1,777
Off-market takeover.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Sean St Clair Mulhearn Non-Executive Director Nov 2015
Mr Mulhearn has been involved in the financial markets for over 30 years with experience in Asia, Europe and the Americas. Sean has expertise in risk management. He founded Jacaranda Capital Partners, a boutique advisory and markets training business with offices in Singapore and Australia. He is Chair of Risk Committee.
Ms Jennifer (Jenny) Swain Chief Executive OfficerExecutive Director May 2016
Ms Swain joined Allegra in February 2011 as National Sales Manager having spent 10 years in a similar role with LifeHealthcare driving the growth of its Orthopaedic sales division.
Dr Nicholas Hartnell Non-Executive Director Mar 2018
Dr Hartnell as an orthopaedic surgeon brings to the Company orthopaedic industry experience. Since then, he has been focused on orthopaedic training and specialization and hence has many years of experience in all facets of Orthopaedic care. Nicholas set up his practice in Bowral in the Southern Highlands, NSW and has since expanded his surgical practice into the Goulburn, and Camden/Campbelltown areas. He is member of the Risk Committee.
Ms Patricia Vanni Company Secretary Jul 2024
-
Patricia Vanni Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Robinwood Investments Pty Ltd 38,274,948 36.64%
Netwealth Investments Limited (Wrap Services A/C) 9,447,356 9.04%
Welsh Superannuation Pty Limited 6,600,000 6.32%
Marie Caroll & Dawson Caroll 5,636,285 5.40%
Bnp Paribas Nominees Pty Ltd Acf Clearstream 4,958,074 4.75%
The University Of Sydney 4,806,000 4.60%
Dr Andrew William Leicester & Mrs Skye Christine Leicester (Leicester Super Fund A/C) 3,353,123 3.21%
Dugal Diagnostics Pty Ltd (The Dugal Family A/C) 3,000,000 2.87%
4 Holes In One Pty Ltd (Number 5 A/C) 3,000,000 2.87%
Dr Andrew William Leicester & Mrs Skye Christine Leicester 2,272,270 2.18%
Chew Investments Pty Ltd (Chew Investments A/C) 1,333,333 1.28%
Mr Nicholas Hartnell 1,224,090 1.17%
Mr Richard Ulrick & Mrs Wendy Ulrick (Ulrick Super Fund A/C) 1,038,318 0.99%
Mr Thomas James Carroll 1,000,000 0.96%
Mr Kenneth Campbell 1,000,000 0.96%
Mergin Investments Pty Ltd (M & V Cross Super Fund A/C) 1,000,000 0.96%
Destin Pty Limited 946,470 0.91%
Misty Hills Nominees Pty Ltd 892,857 0.85%
Mr Fenton Paul Healy (Cheeky Monkey A/C) 545,000 0.52%
Desmond J Bokor Pty Limited (Kooringa Super Fund A/C) 510,000 0.49%

Profile

since

Note